GOD, Family and Country are my priorities and in that Order. Inactive U.S Marine, Semper Fi
Georgia
Joined April 2022
- Tweets4.1K
- Following2.1K
- Followers1.6K
- Likes8.1K
$NWBO @MHRAgovuk @FDA @DrOzCMS @POTUS @Merck @NHSBT @SpimacoAddwaeih
Treatment initially FOR GBM and then future treatment for all Solid Tumors coming in the UK. More Countries will follow as demand will surely rise from the successful treatments that will be seen in UK, similar to the GBM treatment given to Braelyn and many others in the United States. @HollensbeAmanda
"NHS Blood and Transplant's (NHSBT) Therapeutic Apheresis Services (TAS) and Cellular and Molecular Therapies (CMT) teams are supporting the UK production of DCVax®-L – a treatment for Glioblastoma multiforme (GBM), an aggressive form of primary brain cancer, as well as all solid tumours."
🤖 Made with AI
Do not know what to tell you with that, the recent findings are valid and we have not seen that for 3 years, we all want a decision like ages ago, you are not in that boat alone.
Tony, just putting some feasable timelines based on visual facts we see, that is it, you take it as you will. Yes we could get pushed out, but everything has a end date including NWBO
Before open on a Monday, give a week to release other news to crush the shorts, that is if Linda plays her cards right.
$NWBO @NorthwestBio As we now head into the weekend and November nears we now know via the CHM minutes for August 2026 "A medicine used to treat glioblastoma cancer of the brain" was mentioned in the Pre-Hearing section indicating an Oral meeting will be needed to decide whether the data have resolved the questions put to the NorthWest Bio. Based on history and language used in past CHM minutes, specifically in May of 2024 where Eli Lilly was informed for an Oral meeting and then in July the meeting was held resulting in a decision and approval in August of 2024 two months after the Pre-Hearing paragraph on the alzheimer's drug. Will DCVAX-L follow the same timelines ? That is the question or will MHRA ask for even more answers that can't be resolved in meeting. We do not know for sure Oral meeting happened in Sept, but if it did, OCT meeting should be the decision and possible approval for Nov 2026. These are all if's but I believe the timelines are feasable and just maybe we are at the END of the ROAD.
🤖 Made with AI
Not both drugs that were approved for alzheimer's back in August/October 2024 were under same company Eli Lilly, CHM meeting minutes does not differentiate between the two, so really the approval could be stated in happened once in 2024 not twice as shown on Image. Kind of confusing, but PDF spells it out a little better.
Tommy, yes likely Sept with possible outcome in Meeting coming up for OCT, that would only if no new concerns arise, all SEPT is not official yet either so we dont know. I mean it could have skipped SEPT if NWBO was not ready to provide ORAL meeting.
Well as you see we had approvals on some with same verbage context, CHM wanting ORAL meeting does not mean doom and gloom as some may want to lean that way, DCVAX-L is in a league of its own, the complexity of the application along with the new PSM data is July could lend to the Oral presentation being needed to hash the questions and concerns?? Just dont know of course. But why no Oral meeting till now, I would think it has to do with the PSM Data?? PSM data was never part of the application, at least it could not have been cause it just came out in July 2026
$NWBO
I had AI go through all my CHM Meeting files from 2023-2026 looking for comparisons of this statement in every CHM meeting file "The Commission advised that the concerns had not been adequately addressed and the applicants should be invited to address these concerns in oral representations to
the Commission." Attached are my findings , had 2 oral request in 2023, 5 in 2024, 2 in 2025 and ours in 2026. This information is the best I could come with with based on what CHM meetings release to the public and trying to piece together what was approved afterwards.
🤖 Made with AI
$NWBO
It would be reasonable to question why NHSBT would devote specialist capabilities to DCVax-L if the project had no credible future.
NHSBT publicly announced its collaboration with NWBO and Advent Bioservices.
The agreement includes:
Leukapheresis collection of patients' immune cells.
Specialist cell processing and handling.
Initial operations in Leeds and Oxford.
Exploration of expansion to other locations across England.
In regards to CHM meeting notes for August 2026
Well being the NHS Blood and Transplant (NHSBT) collaboration occured after the meeting in SEPT, (Assuming it happened then) it would seem possible the Oral presentation was positive. IMO
$NWBO August CHM Meeting Posted
app.box.com/s/jv487awvqzzsrd…
PRE–HEARING (The Commission considers the company’s written data a month before the
potential oral hearing and decides whether the data have resolved the questions put to the
company)
"A medicine used to treat glioblastoma (a cancer of the brain)."
$NWBO @MHRAgovuk @realDonaldTrump @DrOzCMS Approve DCVAX-L, its time! We now have two Presidents in a matter of two weeks with a focus on GBM and our American President is full aware now of DCVAX-L as seen here last night OCT 21st. xitter.cf/HollensbeAmanda/status…
"A sea change moment" 💛
Professor Richard Gilbertson, Chair of the Tessa Jowell Brain Cancer Mission, reflects on last week's Government announcement which aims to transform treatments for brain tumour patients.
The Prime Minister has set out four steps which aim to speed up the route from research to treatment, including an immediate three-month review, a national action plan for getting treatments to patients faster, and the appointment of a brain cancer clinical lead.
Prof Gilbertson says it is a "sea change moment for those who are battling a brain tumour and all of us across the community who are supporting them".
We collectively remain committed to building on the momentum that has grown over the last year and to working with Government ensure these welcome initiatives deliver meaningful change for patients and their families.
#TogetherWeWillFindACure #BrainTumourResearch
@BrainTumourOrg
@TJBCMission
@brainstrust
@BrainTumourSupp
@FoundationTessa
@CR_UK
@GreatOrmondSt
$NWBO @AlMusella @glioblastomaorg
"We had only about 20–30 seconds with him, and I knew I needed to make every second count.
I introduced him to Braelyn and thanked him for telling Dr. Oz about her brain cancer story."
"I explained that Braelyn had been diagnosed with glioblastoma, the deadliest type of brain tumor, but that today she is CANCER-FREE after receiving DCVax-L, a personalized cancer vaccine developed right here in America!"
"Earlier in the evening, I was also able to give a member of his staff a detailed packet about Braelyn’s journey, DCVax-L, and the obstacles American patients face in accessing promising investigational treatments."
🇺🇸❤️ WE MET PRESIDENT TRUMP TONIGHT! ❤️🇺🇸
What an extraordinary evening for our family!
Tonight, Braelyn, Ben, and I had the incredible opportunity to meet President Trump at the rally in Pendleton, South Carolina!
We had only about 20–30 seconds with him, and I knew I needed to make every second count.
I introduced him to Braelyn and thanked him for telling Dr. Oz about her brain cancer story.
I explained that Braelyn had been diagnosed with glioblastoma, the deadliest type of brain tumor, but that today she is CANCER-FREE after receiving DCVax-L, a personalized cancer vaccine developed right here in America!
Yet we must travel all the way to England for her ongoing treatments because we cannot access it here in the United States.
Then something pretty cool happened!
President Trump turned to one of his staffers and instructed them to get me in touch with Dr. Oz!
I also expressed my hope that we could connect with Secretary Kennedy.
As our brief time together came to an end, I made one final appeal:
“Please help bring this American-made treatment back home to America.”
President Trump was incredibly gracious to our family and very kind to Braelyn. We are so grateful for the opportunity to speak with him!
Earlier in the evening, I was also able to give a member of his staff a detailed packet about Braelyn’s journey, DCVax-L, and the obstacles American patients face in accessing promising investigational treatments.
Now we are praying that the connection with Dr. Oz comes through!
Three years ago, Braelyn was given just months to live. Today, she’s 19, attending college, and her latest MRI shows NO EVIDENCE OF DISEASE RECURRENCE!
Tonight, we had the opportunity to bring her story directly to the President of the United States. ❤️
My prayer is that this opens the door to a much bigger conversation—one that could change the future for countless American cancer patients.
📸 We were not permitted to bring our phones into the private meeting with President Trump, so we couldn’t take our own pictures with him. His staff took an official photograph of us together, which we’re told will be emailed to us. I can’t wait to share it! In the meantime, here are some pictures from our unforgettable evening.
Thank you to EVERYONE who helped make tonight possible and to all of you who continue to share Braelyn’s story. You helped us get this far, and we’re not stopping now! ❤️🙏
@realDonaldTrump @DrOzCMS @WhiteHouse
#DCVaxForBraelyn #DCVax
